Anneli Nilsson

437 total citations
11 papers, 284 citations indexed

About

Anneli Nilsson is a scholar working on Oncology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Anneli Nilsson has authored 11 papers receiving a total of 284 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 9 papers in Immunology and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Anneli Nilsson's work include CAR-T cell therapy research (8 papers), Immunotherapy and Immune Responses (8 papers) and Cancer Immunotherapy and Biomarkers (5 papers). Anneli Nilsson is often cited by papers focused on CAR-T cell therapy research (8 papers), Immunotherapy and Immune Responses (8 papers) and Cancer Immunotherapy and Biomarkers (5 papers). Anneli Nilsson collaborates with scholars based in Sweden, Denmark and Japan. Anneli Nilsson's co-authors include Yoshiyuki Sankai, Hiroaki Kawamoto, Jörgen Borg, Peter Ellmark, Adnan Deronic, Sandra Irenaeus, Niina Veitonmäki, Dorte Nielsen, Jeffrey Yachnin and Gustav Ullenhag and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Molecular Biology and Cancer Research.

In The Last Decade

Anneli Nilsson

11 papers receiving 275 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anneli Nilsson Sweden 5 130 94 93 92 43 11 284
Yanjin He China 8 47 0.4× 18 0.2× 11 0.1× 40 0.4× 16 0.4× 34 206
Mayumi Endo United States 9 7 0.1× 68 0.7× 17 0.2× 17 0.2× 43 1.0× 39 368
Ayaka Maeda Japan 9 21 0.2× 40 0.4× 17 0.2× 42 0.5× 14 0.3× 16 192
Qian Lai China 9 61 0.5× 54 0.6× 16 0.2× 36 0.4× 8 0.2× 31 437
Alireza Soltani Khaboushan Iran 10 14 0.1× 82 0.9× 11 0.1× 17 0.2× 22 0.5× 28 354
Sarah E. Blitz United States 7 7 0.1× 31 0.3× 28 0.3× 46 0.5× 14 0.3× 27 227
Jana Knuever Germany 10 26 0.2× 15 0.2× 38 0.4× 36 0.4× 4 0.1× 18 349
Tomonori Yamauchi Japan 9 16 0.1× 49 0.5× 13 0.1× 5 0.1× 14 0.3× 11 283
Teruasa Murata Japan 12 18 0.1× 19 0.2× 26 0.3× 16 0.2× 10 0.2× 25 321
Jessica Izzi United States 7 14 0.1× 28 0.3× 14 0.2× 5 0.1× 11 0.3× 21 167

Countries citing papers authored by Anneli Nilsson

Since Specialization
Citations

This map shows the geographic impact of Anneli Nilsson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anneli Nilsson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anneli Nilsson more than expected).

Fields of papers citing papers by Anneli Nilsson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anneli Nilsson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anneli Nilsson. The network helps show where Anneli Nilsson may publish in the future.

Co-authorship network of co-authors of Anneli Nilsson

This figure shows the co-authorship network connecting the top 25 collaborators of Anneli Nilsson. A scholar is included among the top collaborators of Anneli Nilsson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anneli Nilsson. Anneli Nilsson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
2.
Fritzell, Sara, Anneli Nilsson, Karin Barchan, et al.. (2023). ATOR-1017 (evunzekibart), an Fc-gamma receptor conditional 4-1BB agonist designed for optimal safety and efficacy, activates exhausted T cells in combination with anti-PD-1. Cancer Immunology Immunotherapy. 72(12). 4145–4159. 6 indexed citations
3.
Nilsson, Anneli, et al.. (2022). Abstract 4155: Mitazalimab, a potent CD40 agonist in combination with chemotherapy redirects and activates tumor infiltrating myeloid cells. Cancer Research. 82(12_Supplement). 4155–4155. 1 indexed citations
4.
5.
Deronic, Adnan, et al.. (2021). Abstract 1593: Mitazalimab, a potent CD40 agonist with potential for combination with chemotherapy. Cancer Research. 81(13_Supplement). 1593–1593. 1 indexed citations
6.
Nelson, Michelle H., Robert E. Miller, Anneli Nilsson, et al.. (2020). 851 Potent tumor-directed T cell activation and in vivo tumor inhibition induced by a 4–1BB x 5T4 ADAPTIR™ bispecific antibody. SHILAP Revista de lepidopterología. A507.1–A507. 2 indexed citations
7.
Irenaeus, Sandra, Dorte Nielsen, Peter Ellmark, et al.. (2019). First‐in‐human study with intratumoral administration of a CD40 agonistic antibody, ADC‐1013, in advanced solid malignancies. International Journal of Cancer. 145(5). 1189–1199. 76 indexed citations
8.
Dahlman, Anna, Michelle H. Nelson, Anneli Nilsson, et al.. (2019). Abstract 2380: Preclinical safety and efficacy of a tumor-directed T cell activating 4-1BB x 5T4 ADAPTIR™ bispecific antibody. Cancer Research. 79(13_Supplement). 2380–2380. 2 indexed citations
9.
Nilsson, Anneli. (2016). Effect of continuity, area, connectivity and surrounding landscape on forest specialist plant species in deciduous forest. KTH Publication Database DiVA (KTH Royal Institute of Technology). 1 indexed citations
10.
Nilsson, Anneli, et al.. (2014). Gait training early after stroke with a new exoskeleton – the hybrid assistive limb: a study of safety and feasibility. Journal of NeuroEngineering and Rehabilitation. 11(1). 92–92. 159 indexed citations
11.
Andersson, Kerstin, et al.. (2003). Identification of the Antigenic Epitopes in Staphylococcal Enterotoxins A and E and Design of a Superantigen for Human Cancer Therapy. Journal of Molecular Biology. 333(5). 893–905. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yanjin He Breakdown of academic impact, for papers by Mayumi Endo Breakdown of academic impact, for papers by Ayaka Maeda Breakdown of academic impact, for papers by Qian Lai Breakdown of academic impact, for papers by Alireza Soltani Khaboushan Breakdown of academic impact, for papers by Sarah E. Blitz Breakdown of academic impact, for papers by Jana Knuever Breakdown of academic impact, for papers by Tomonori Yamauchi Breakdown of academic impact, for papers by Teruasa Murata Breakdown of academic impact, for papers by Jessica Izzi
Rankless by CCL
2026